Nicholas Piramal India: Survival Strategies for International Patent Law Regime



IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed

Code : COM0034

Year : 2004

Industry : Health Care

Region : USA India

Teaching Note:Not Available

Structured Assignment :Not Available
Buy This Case Study
OR
       

Abstract: The Indian pharmaceutical industry is on the verge of a major turnaround with the proposed implementation of International Patent Law (IPL) from January 2005 onwards.

This means that India's pharmaceutical companies will have to strictly adhere to product patent laws and not the process patent laws that it has followed to date.

Indian companies were reverse engineering the patented drugs and, with minor changes in the process, launched them in the domestic markets at cheaper rates.

The enforcement of the law would necessiate the Indian companies to complete with global pharma majors to stay in business. Thus, Indian companies have increased investments in research and development (R&D), joint ventures and also have elaborated their marketing efforts.

For Case Books Click Here >>

For Case eBooks Click Here >>

Pedagogical Objectives:

  • To discuss the impact of international patent law on the Indian pharmaceutical industry and how NPIL planned to meet the product patent challenge
  • To discuss the various efforts taken by Nicholas Piramal India Limited (NPIL) to stay competitive in the post-2005 period
  • To discuss the strategic approaches followed by NPIL to face the global competitive market and the company's focus on joint ventures more than on R&D
  • To discuss the multiprolonged strategic approach for growth
  • To discuss the multifaceted strategies adopted by Nicholas Piramal India Limited to cope with the on-coming implementation of international patent law from January 1st 2005
  • To discuss the problems that NPIL would have to face in the future with its adopted strategies.

    Keywords : Survival strategy - Nicholas Piramal India Limited (NPIL); Indian pharmaceutical industry; Generic drugs; Drug price controls; Business strategy; Joint Ventures, alliances and partnerships; International patent law, Indian Patent Act; 1976; Product; Corporate Strategies Case Study; process patents; Mergers and acquisitions; Organic, inorganic growth strategy; Research and development; New chemical entities (NCE); Marketing and branding; Trade related aspects of intellectual property rights; General agreement on trade and tariffs (GATT)

    Contents :
    » The Indian Pharmaceutical Industry
    » Evolution of Nicholas Piramal
    » NPIL’s Business Strategy


    Case Introduction >>


    • Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
    Mob: +91- 9640901313,
    E-mail: casehelpdesk@ibsindia.org

    ©2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap